Mr Mrs Miss Ms Dr Other

Dr
Nienke
Lubben

Partner & Patent Attorney

York Office The Hague Office

Life sciences

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 777 265 2294
Email. nlubben@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Nienke is a European and UK Patent Attorney. Her client base includes several universities, start-ups, independent research institutes and small to medium enterprises. She advises on IP portfolio management and strategy, drafting, patent prosecution, freedom to operate and due diligence relating to potential asset licencing, acquisition or investment. Her extensive experience in drafting and analysing the value of third party patents and patent applications has given her a good understanding of how to prepare patent applications that are attractive to potential investors and licensees. In terms of technologies, Nienke specialises in the field of cell and gene therapy, with particular experience in TCR and CAR-T cell therapies. She has experience in a diverse range of technical subject matter including antibody and peptide therapeutics, viral vector production, biomarkers and diagnostic methods. She has a PhD in cell biology and immunology.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biological Sciences (genetics)

PHD

Cell Biology and Immunology

Recognition

MIP IP Rising Star 2019/20

MIP IP Rising Star 2018/19

Publications

Managing Intellectual Property firm rankings - IP Stars 2024

View publication online

MIP IP Rising Stars 2019/20

View publication online

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article
Event - 23rd September 2025

Upcoming Webinar: Strategies for engaging with the EPO and JPO to get the Examiner on your side

Date: 20th October 2025 Time: 4.30 PM EDT | 1.30 PM PDT HGF and SHIGA are hosting an exclusive webinar exploring effective strategies for engaging with patent examiners at the European Patent …

Event details

Fashionably IP Podcast – Episodes 41-50 – exploring hot topics in the world of fashion and intellectual property

Episodes 41-50 of the Fashionably IP Podcast where we will be looking at important hot topics in the world of fashion and intellectual property. We will be focusing on key …

Read article

Agritech Thymes: A review of protection for gene edited plants

As we head into a new season, it’s a good time to revisit the current status of protection for Essentially Derived Varieties (EDVs) and plants derived from New Genomic Techniques …

Read article

Avoiding Legal Pitfalls: The Notting Hill Bag Company's Costly Mistake

[2025] EWHC 1793 (IPEC) – Natasha Courtenay-Smith and Notting Hill Bag Company Limited v The Notting Hill Shopping Bag Company Limited, Nangialai Takanai, The Notting Hill Shopper Bag Ltd, Ehsanullah …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.